Skip to main content
Aprogen, Inc logo

Aprogen, Inc — Investor Relations & Filings

Ticker · 007460 ISIN · KR7007460009 KO Manufacturing
Filings indexed 737 across all filing types
Latest filing 2022-04-04 Regulatory Filings
Country KR South Korea
Listing KO 007460

Aprogen, Inc. is a biopharmaceutical company focused on the research, development, and manufacturing of biologic medicines. The company's core activities are centered on developing both biosimilars and novel drugs, including new protein therapeutics and bispecific antibodies. Its product development is based on proprietary technologies in antibody engineering and recombinant protein engineering.

Recent filings

Filing Released Lang Actions
[기재정정]투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding a 'Correction Report' (정정신고) for a 'Major Management Matter' (주요경영사항) concerning the acquisition of a patent. It details a correction of a clerical error regarding the country of patent issuance. Since this is a specific regulatory announcement regarding corporate material events that does not fall into the other specialized categories like M&A, dividends, or financial reports, it is classified as a general Regulatory Filing (RNS).
2022-04-04 Korean
사업보고서 (2021.12)
Audit Report / Information Classification · 100% confidence The document is a comprehensive 'Audit Report' (감사보고서) for Aprogen Medicines, including the independent auditor's report, consolidated financial statements (balance sheet, income statement, statement of changes in equity, cash flow statement), and detailed notes. It covers the fiscal year ending December 31, 2021. While it contains financial data, it is a formal audit report rather than a 10-K (which is a specific US regulatory filing) or a simple earnings release. Given the structure and content, it fits the 'Audit Report' category. FY 2021
2022-03-31 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual relationships (such as collateral) of major shareholders and their special relations. This falls under the 'Major Shareholding Notification' category.
2022-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (Aprogen MED) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion, key financial data (assets, liabilities, profit/loss), and details about the external auditor. While it contains financial data, it is a formal notification of the submission of the audit report to the regulatory body (KRX), rather than the full annual report (10-K) or a standalone audit report document. Given the short length and the nature of the filing as a regulatory notification of report submission, it fits the 'Report Publication Announcement' (RPA) category. FY 2021
2022-03-23 Korean
투자판단관련주요경영사항(특허취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korea Exchange (KRX) system, specifically a 'Major Management Matter' (투자판단 관련 주요경영사항) disclosure regarding the acquisition of a patent in China. Since this is a specific regulatory disclosure of a material event that does not fit into categories like financial reports, M&A, or dividends, it falls under the 'Regulatory Filings' (RNS) category.
2022-03-08 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a corporate merger (회사합병 결정) between Aprogen Medicines and Aprogen. It details the merger schedule, valuation ratios, and legal procedures for shareholder dissent. This type of filing is a formal announcement of M&A activity, which falls under the 'M&A Activity' category.
2022-03-04 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.